Schedule 13G ownership disclosure
CERO THERAPEUTICS HLDGS INC
Security class unavailable · CUSIP: 71902K105
Event date: 2024-09-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 21,067,956
- Percent of class
- 14.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-24-001976
- Form type
- SC 13G
- Filer
- CERO THERAPEUTICS HOLDINGS, INC.
- CIK
- CIK 1870404
- Filed
- Nov 20, 2024
- Reporting period
- Sep 24, 2024
- Description
- Schedule 13G beneficial ownership